Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8843
|
| pubmed:dateCreated |
1993-3-18
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
20
|
| pubmed:volume |
341
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
495-6
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8094516-Blood Platelets,
pubmed-meshheading:8094516-Erythropoietin,
pubmed-meshheading:8094516-Fibrinolysis,
pubmed-meshheading:8094516-Humans,
pubmed-meshheading:8094516-Kidney Failure, Chronic,
pubmed-meshheading:8094516-Platelet Aggregation,
pubmed-meshheading:8094516-Recombinant Proteins
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Erythropoietin and fibrinolysis effects on platelet activity.
|
| pubmed:publicationType |
Letter
|